OLR1 and colonic neoplasm: The results documented that the sensitivity of LoVo colon cancer cells to DDP, oxaliplatin, 5-Fu, and paclitaxel was obviously increased, P-gp expression was significantly decreased, and SMAD4 expression was clearly enhanced after knocking down OLR1 (Fig. 2G, H).